Home > Insider Trading > Filing (0001104659-23-081729)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1974640	Apogee Therapeutics Inc.	APGE	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1663607	Evan Peter Harwin	2001 Market Street Suite 2500 Philadelphia PA 19103	Yes	No	No	No
1686157	L.p. Fund Healthcare Fairmount	2001 Market Street Suite 2500 Philadelphia PA 19103	Yes	No	No	No
1769651	L.p. Ii Fund Healthcare Fairmount	200 Barr Harbor Drive Suite 400 West Conshohocken PA 19428	Yes	No	No	No
1802528	Fairmount Funds Management Llc	200 Barr Harbor Drive Suite 400 West Conshohocken PA 19428	Yes	No	No	No
1830177	Tomas Kiselak	2001 Market Street Suite 2500 Philadelphia PA 19103	Yes	No	No	No
1982189	Fairmount Healthcare Co-Invest Ii L.p.	200 Barr Harbor Drive Suite 400 West Conshohocken PA 19428	Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-07-13	55,913	$17.00	55,913	No	4	P	Indirect	By Fairmount Healthcare Fund LP
Common Stock	Acquisiton	2023-07-13	1,992,734	$17.00	1,992,734	No	4	P	Indirect	By Fairmount Healthcare Fund II LP
Common Stock	Acquisiton	2023-07-13	892,529	$17.00	892,529	No	4	P	Indirect	By Fairmount Healthcare Co-Invest II LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Fairmount Healthcare Fund LP
No	4	P	Indirect	By Fairmount Healthcare Fund II LP
No	4	P	Indirect	By Fairmount Healthcare Co-Invest II LP

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2023-07-13	47,758	$0.00	47,758	$17.00
Common Stock	Stock Option (Right to Buy)	Acquisiton	2023-07-13	47,758	$0.00	47,758	$17.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
47,758		2033-07-13	No	4	A	Direct
47,758		2033-07-13	No	4	A	Direct

Footnotes

Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date.
Under Mr. Harwin's arrangement with Fairmount, Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock.
Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock.